Market By Product, Application, And Geography | Forecast 2019-2028
Triton Market Research predicts that the global market for opioid drugs market is anticipated to rise with a CAGR of 2.56% during the forecast period 2019-2028. The market was valued at $26.91 billion in the year 2019, and is expected to rise to a revenue of about $33.78 billion by the year 2028.
Opioids are used as a pain reliever, as they comprise the chemicals that can relax the muscles and can relieve pain and stress. Although some opioids can be used to treat coughing and diarrhea, prescription opioids are majorly used to treat moderate to severe pain. The report focuses on prescription opioid drugs, which include hydrocodone, oxycodone, codeine, fentanyl, methadone, morphine, and others. In addition, it focuses on various opioid applications, such as pain management, cough treatment, and diarrhea treatment.
Report scope can be customized per your requirements. Request For Customization
Triton Market Research’s report on the opioid drugs market provides an in-depth insight into the market. The detailed analysis of the market includes key market insights, Porter’s five force analysis, and market attractiveness index. Â
Factors such as the growth in medical cases and the rising prevalence of cancer, increase in the use of abuse-deterrent formulations to restrict the rise of opioid dependence, and the growing demand for palliative therapy are expected to foster the growth of the market during the forecast period. The increase in the number of medical cases results in a simultaneous need for pain killers and various opioids. Especially, the rising rate at which cancer is consuming the global medical industry showcases the need and importance of the use of opioids in a better manner, while still trying to reduce the dependence on these products. This not only creates a large market, but showcases the global need of knowledge on how to use opioids as they are necessary for various treatments. This will result in increased demand and usage of opioids, leading to the growth of the market.
Furthermore, to battle the opioid epidemic, there has been a significant increase in investments towards technological advancements in various pharmaceutical agencies to optimize the drug formulations. This will boost the demand for opioid drugs and also increase the commercial success of these drugs.
Opoids have a very strong likelihood of causing addiction. Due to this, various governments have strict rules and regulations. This not only causes a strain on the market, but also a fear among people who may need it to be treated. The spread of the opioid epidemic and the increase in the number of deaths due to opioid overdoses act as major challenges faced by the vendors in the market. Furthermore, complications due to the increasing number of lawsuits and the rise in the usage of opioid drugs for non-medical purposes also act as restraints.
Key geographies covered in the global opioid drugs market are:
•          North America: United States and Canada
•          Europe: United Kingdom, France, Germany, Spain, Italy, Russia, and Rest of Europe
•          Asia-Pacific: China, Japan, India, Australia, South Korea, ASEAN countries, and Rest of Asia-Pacific,
•          Latin America: Brazil, Mexico, and Rest of Latin America
•          Middle East and Africa: Saudi Arabia, Turkey, United Arab Emirates, South Africa, and Rest of Middle East & Africa
The segmentation analysis of the opioid drugs market includes product and application.
•          Product is sub-segmented into:
o         Buprenorphine
o         Fentanyl
o         Hydrocodone
o         Morphine
o         Oxycodone
o         Tramadol
o         Other products
•          Application is sub-segmented into:
o         Pain relief
•          Cancer pain
•          Postoperative pain management
•          Lower back pain
•          Orthopedic
•          Neuropathic
•          Fibromyalgia
o         Anesthesia
o         Cough suppression
o         Diarrhea suppression
o         Deaddiction
The key companies profiled in the report include Indivior Inc, Hikma Pharmaceuticals Plc, Allergan (Acquired By Abbvie), Collegium Pharmaceutical Inc, Lupin Ltd, Daiichi Sankyo, Biodelivery Sciences International Inc, Mylan NV, Lannett Co Inc, Sun Pharmaceutical Industries Ltd, Purdue Pharma LP, Pfizer Inc, Acura Pharmaceuticals, Johnson Johnson, Cipher Pharmaceuticals Inc, Janssen Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, and Sanofi-Aventis SA.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1.   GLOBAL OPIOID DRUGS MARKET - SUMMARY
2.   INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1.  NEW OPPORTUNITIES FOR PHARMACEUTICAL COMPANIES IN THE US
2.2.2.  TECHNOLOGICAL ADVANCEMENTS TO FIGHT AGAINST OPIOID DRUG CRISIS
2.2.3. Â DIFFERENT SOURCES OF PROCURING OPIOIDS
2.3. PORTER’S FIVE FORCE ANALYSIS
2.3.1.  THREAT OF NEW ENTRANTS
2.3.2.  THREAT OF SUBSTITUTE
2.3.3.  BARGAINING POWER OF SUPPLIERS
2.3.4.  BARGAINING POWER OF BUYERS
2.3.5. Â THREAT OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. MARKET DRIVERS
2.6.1. GROWTH IN MEDICAL CASES & RISING PREVALENCE OF CANCER
2.6.2. INCREASE IN THE USE OF ABUSE-DETERRENT FORMULATIONS TO RESTRICT THE RISE OF OPIOID DEPENDENCE
2.6.3. DEMAND FOR PALLIATIVE THERAPY
2.7. MARKET RESTRAINTS
2.7.1.  GOVERNMENT RULES AND REGULATIONS
2.7.2. INCREASED NUMBER OF LAWSUITS AGAINST THE MANUFACTURERS OF OPIOID DRUGS
2.7.3. USAGE OF OPIOIDS FOR NON-MEDICAL PURPOSES
2.8. MARKET OPPORTUNITIES
2.8.1. RISING COMMERCIAL SUCCESS AND MARKET SHARE OF OPIOID DRUGS
2.8.2. GROWTH OF INVESTMENTS IN RESEARCH OF PHARMACEUTICAL USES OF OPIOIDS
2.9. MARKET CHALLENGES
2.9.1. OPIOID EPIDEMIC SPREADING
2.9.2. RISING DEATH RATE DUE TO OPIOID OVERDOSE
2.10. COVID-19 IMPACT ON THE GLOBAL OPIOID DRUGS MARKET
3.   GLOBAL OPIOID DRUGS MARKET OUTLOOK - BY PRODUCT
3.1. BUPRENORPHINE
3.2. FENTANYL
3.3. HYDROCODONE
3.4. MORPHINE
3.5. OXYCODONE
3.6. TRAMADOL
3.7. OTHER PRODUCTS
4.   GLOBAL OPIOID DRUGS MARKET OUTLOOK - BY APPLICATION
4.1. PAIN RELIEF
4.1.1. CANCER PAIN
4.1.2. POSTOPERATIVE PAIN MANAGEMENT
4.1.3. LOWER BACK PAIN
4.1.4. ORTHOPEDIC
4.1.5. NEUROPATHIC
4.1.6. FIBROMYALGIA
4.2. ANESTHESIA
4.3. COUGH SUPPRESSION
4.4. DIARRHEA SUPPRESSION
4.5. DE-ADDICTION
5.   GLOBAL OPIOID DRUGS MARKET – REGIONAL OUTLOOK
5.1. NORTH AMERICA
5.1.1.  MARKET BY PRODUCT
5.1.2.  MARKET BY APPLICATION
5.1.2.1.     MARKET BY PAIN RELIEF
5.1.3.  COUNTRY ANALYSIS
5.1.3.1.     UNITED STATES
5.1.3.2.     CANADA
5.2. EUROPE
5.2.1.  MARKET BY PRODUCT
5.2.2.  MARKET BY APPLICATION
5.2.2.1.     MARKET BY PAIN RELIEF
5.2.3.  COUNTRY ANALYSIS
5.2.3.1.     UNITED KINGDOM
5.2.3.2.     GERMANY
5.2.3.3.     FRANCE
5.2.3.4.     SPAIN
5.2.3.5.     ITALY
5.2.3.6.     RUSSIA
5.2.3.7.     REST OF EUROPE
5.3. ASIA-PACIFIC
5.3.1.  MARKET BY PRODUCT
5.3.2.  MARKET BY APPLICATION
5.3.2.1.     MARKET BY PAIN RELIEF
5.3.3.  COUNTRY ANALYSIS
5.3.3.1.     CHINA
5.3.3.2.     JAPAN
5.3.3.3.     INDIA
5.3.3.4.     SOUTH KOREA
5.3.3.5.     ASEAN COUNTRIES
5.3.3.6.     AUSTRALIA & NEW ZEALAND
5.3.3.7.     REST OF ASIA-PACIFIC
5.4. LATIN AMERICA
5.4.1.  MARKET BY PRODUCT
5.4.2.  MARKET BY APPLICATION
5.4.2.1.     MARKET BY PAIN RELIEF
5.4.3.  COUNTRY ANALYSIS
5.4.3.1.     BRAZIL
5.4.3.2.     MEXICO
5.4.3.3.     REST OF LATIN AMERICA
5.5. MIDDLE EAST AND AFRICA
5.5.1.  MARKET BY PRODUCT
5.5.2.  MARKET BY APPLICATION
5.5.2.1.     MARKET BY PAIN RELIEF
5.5.3.  COUNTRY ANALYSIS
5.5.3.1.     UNITED ARAB EMIRATES
5.5.3.2.     TURKEY
5.5.3.3.     SAUDI ARABIA
5.5.3.4.     SOUTH AFRICA
5.5.3.5.     REST OF MIDDLE EAST & AFRICA
6.   COMPETITIVE LANDSCAPE
6.1. ACURA PHARMACEUTICALS
6.2. BIODELIVERY SCIENCES INTERNATIONAL INC
6.3. CIPHER PHARMACEUTICALS INC
6.4. ALLERGAN (ACQUIRED BY ABBVIE)
6.5. COLLEGIUM PHARMACEUTICAL INC
6.6. DAIICHI SANKYO
6.7. HIKMA PHARMACEUTICALS PLC
6.8. INDIVIOR INC
6.9. JANSSEN PHARMACEUTICALS INC
6.10. JOHNSON JOHNSON
6.11. LANNETT CO INC
6.12. LUPIN LTD
6.13. MYLAN NV
6.14. PFIZER INC
6.15. PURDUE PHARMA LP
6.16. SANOFI-AVENTIS SA
6.17. SUN PHARMACEUTICAL INDUSTRIES LTD
6.18. TEVA PHARMACEUTICAL INDUSTRIES LTD
7.   METHODOLOGY & SCOPE
7.1. RESEARCH SCOPE & DELIVERABLES
7.2. SOURCES OF DATA
7.3. RESEARCH METHODOLOGY
TABLE 1: GLOBAL OPIOID DRUGS MARKET, BY GEOGRAPHY, 2019-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: GLOBAL OPIOID DRUGS MARKET, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE 4: GLOBAL OPIOID DRUGS MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 5: GLOBAL OPIOID DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)
TABLE 6: GLOBAL OPIOID DRUGS MARKET, BY GEOGRAPHY, 2019-2028 (IN $ MILLION)
TABLE 7: NORTH AMERICA OPIOID DRUGS MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA OPIOID DRUGS MARKET, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA OPIOID DRUGS MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA OPIOID DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)
TABLE 11: EUROPE OPIOID DRUGS MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 12: EUROPE OPIOID DRUGS MARKET, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE 13: EUROPE OPIOID DRUGS MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 14: EUROPE OPIOID DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC OPIOID DRUGS MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 16: ASIA-PACIFIC OPIOID DRUGS MARKET, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE 17: ASIA-PACIFIC OPIOID DRUGS MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 18: ASIA-PACIFIC OPIOID DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)
TABLE 19: LATIN AMERICA GLOBAL OPIOID DRUGS MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 20: LATIN AMERICA OPIOID DRUGS MARKET, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE 21: LATIN AMERICA OPIOID DRUGS MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 22: LATIN AMERICA OPIOID DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)
TABLE 23: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 24: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE 25: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 26: MIDDLE EAST AND AFRICA OPIOID DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCE ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: GLOBAL OPIOID DRUGS MARKET, BY BUPRENORPHINE, 2019-2028 (IN $ MILLION)
FIGURE 4: GLOBAL OPIOID DRUGS MARKET, BY FENTANYL , 2019-2028 (IN $ MILLION)
FIGURE 5: GLOBAL OPIOID DRUGS MARKET, BY HYDROCODONE, 2019-2028 (IN $ MILLION)
FIGURE 6: GLOBAL OPIOID DRUGS MARKET, BY MORPHINE, 2019-2028 (IN $ MILLION)
FIGURE 7: GLOBAL OPIOID DRUGS MARKET, BY OXYCODONE, 2019-2028 (IN $ MILLION)
FIGURE 8: GLOBAL OPIOID DRUGS MARKET, BY TRAMADOL , 2019-2028 (IN $ MILLION)
FIGURE 9: GLOBAL OPIOID DRUGS MARKET, BY OTHER PRODUCTS , 2019-2028 (IN $ MILLION)
FIGURE 10: GLOBAL OPIOID DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)
FIGURE 11: GLOBAL OPIOID DRUGS MARKET, BY CANCER PAIN, 2019-2028 (IN $ MILLION)
FIGURE 12: GLOBAL OPIOID DRUGS MARKET, BY POSTOPERATIVE PAIN MANAGEMENT, 2019-2028 (IN $ MILLION)
FIGURE 13: GLOBAL OPIOID DRUGS MARKET, BY LOWER BACK PAIN, 2019-2028 (IN $ MILLION)
FIGURE 14: GLOBAL OPIOID DRUGS MARKET, BY ORTHOPEDIC, 2019-2028 (IN $ MILLION)
FIGURE 15: GLOBAL OPIOID DRUGS MARKET, BY NEUROPATHIC, 2019-2028 (IN $ MILLION)
FIGURE 16: GLOBAL OPIOID DRUGS MARKET, BY FIBROMYALGIA, 2019-2028 (IN $ MILLION)
FIGURE 17: GLOBAL OPIOID DRUGS MARKET, BY ANESTHESIA, 2019-2028 (IN $ MILLION)
FIGURE 18: GLOBAL OPIOID DRUGS MARKET, BY COUGH SUPPRESSION, 2019-2028 (IN $ MILLION)
FIGURE 19: GLOBAL OPIOID DRUGS MARKET, BY DIARRHEA SUPPRESSION, 2019-2028 (IN $ MILLION)
FIGURE 20: GLOBAL OPIOID DRUGS MARKET, BY DE-ADDICTION, 2019-2028 (IN $ MILLION)
FIGURE 21: GLOBAL OPIOID DRUGS MARKET, REGIONAL OUTLOOK 2019 & 2028 (IN %)
FIGURE 22: UNITED STATES OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 23: CANADA OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 24: UNITED KINGDOM OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 25: GERMANY OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 26: FRANCE OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 27: SPAIN OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 28: ITALY OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 29: RUSSIA OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 30: REST OF EUROPE OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 31: CHINA OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 32: JAPAN OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 33: INDIA OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 34: SOUTH KOREA OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 35: ASEAN COUNTRIES OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 36: AUSTRALIA & NEW ZEALAND OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 37: REST OF ASIA-PACIFIC OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 38: BRAZIL OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 39: MEXICO OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 40: REST OF LATIN AMERICA OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 41: UNITED ARAB EMIRATES OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 42: TURKEY OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 43: SAUDI ARABIA OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 44: SOUTH AFRICA OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 45: REST OF MIDDLE EAST & AFRICA OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)